CausalSentinel

Protein Dossier — SERPINF2 (Alpha-2-antiplasmin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Heel bone mineral density (BMD) T-score automated 0.0514 0.017 0.00255 Wald ratio 1 cis NA
Creatinine (enzymatic) in urine 0.0375 0.0126 0.00291 Wald ratio 1 cis NA
Potassium in urine 0.0392 0.0134 0.00334 Wald ratio 1 cis NA
Weight 0.0285 0.0116 0.0142 Wald ratio 1 cis NA
Diagnoses - main ICD10: M54 Dorsalgia 0.204 0.084 0.015 Wald ratio 1 cis NA
Eye problems or disorders: Cataract -0.219 0.0903 0.0153 Wald ratio 1 cis NA
Non-cancer illness code self-reported: vaginal prolapse or uterine prolapse 0.312 0.133 0.0192 Wald ratio 1 cis NA
Diagnoses - main ICD10: K60 Fissure and fistula of anal and rectal regions 0.334 0.143 0.0194 Wald ratio 1 cis NA
Body mass index (BMI) 0.0307 0.0132 0.0196 Wald ratio 1 cis NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis 0.329 0.142 0.0207 Wald ratio 1 cis NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine -0.268 0.123 0.0296 Wald ratio 1 cis NA
Diagnoses - main ICD10: I83 Varicose veins of lower extremities 0.167 0.0783 0.0327 Wald ratio 1 cis NA
…and 63 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3024_18_2 a2-Antiplasmin Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

50 association rows across 37 traits (45 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Albumin (maximum, inv-norm transformed) 1e-60 rs2070863 1 GCST90479503 no MR -> candidate analysis
Serum albumin levels 9e-53 rs1057335 3 GCST90019493 no MR -> candidate analysis
Albumin (mean, inv-norm transformed) 2e-50 rs2070863 2 GCST90479504 no MR -> candidate analysis
Albumin levels 3e-40 rs4790286 2 GCST90662867 no MR -> candidate analysis
Calcium levels 4e-34 rs1057335 1 GCST90019500 no MR -> candidate analysis
Albumin (minimum, inv-norm transformed) 6e-31 rs2070863 1 GCST90479505 no MR -> candidate analysis
Calcium (mean, inv-norm transformed) 5e-30 rs2070863 1 GCST90479530 no MR -> candidate analysis
Triglyceride levels 9e-29 rs7501750 1 GCST90662893 no MR -> candidate analysis
Calcium (maximum, inv-norm transformed) 1e-26 rs2070863 1 GCST90479529 no MR -> candidate analysis
Alzheimer’s disease or family history of Alzheimer’s disease 5e-23 rs1306536849 1 GCST90624094 no MR -> candidate analysis
Testosterone levels 2e-20 rs3976 3 GCST90483498 no MR -> candidate analysis
Total testosterone levels 3e-20 rs4525526 4 GCST90012113 no MR -> candidate analysis
…and 25 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 285 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
alpha-2-plasmin inhibitor deficiency 0.759 established (curated) no MR -> candidate analysis
Congenital alpha2 antiplasmin deficiency 0.608 established (curated) no MR -> candidate analysis
Abnormal bleeding 0.608 established (curated) no MR -> candidate analysis
hypogonadism 0.55 common-variant locus no MR -> candidate analysis
Hodgkins lymphoma 0.545 common-variant locus no MR -> candidate analysis
metabolic disease 0.456 common-variant locus no MR -> candidate analysis
hyperlipidemia 0.444 common-variant locus no MR -> candidate analysis
adolescent idiopathic scoliosis 0.204 common-variant locus no MR -> candidate analysis
Abnormality of the skeletal system 0.091 common-variant locus no MR -> candidate analysis
Alzheimer disease 0.042 common-variant locus no MR -> candidate analysis
gout 0.054 common-variant locus MR: beta=-0.104, p=0.403 (cis)

Of the 11 rows above, 10 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.97, LOEUF=0.513 — LoF-INTOLERANT
GWAS Catalog 106 unique SNPs / 212 rows
ClinVar 209 records; 4 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance